AVTR
Medical Instruments & Supplies · Healthcare
CFO
2023-08-07–present
Equibles does not estimate personal net worth.
Get an email with a short summary when Avantor, Inc. publishes a filing, an earnings call transcript or a press release.
Get AVTR alertsR. Brent Jones is recorded as CFO at Avantor, Inc. (AVTR) since August 7, 2023. Avantor, Inc. reported in an 8-K filed April 1, 2026 that R. Brent Jones resigned as Executive Vice President and Chief Financial Officer. Avantor, Inc. reported in an 8-K filed July 13, 2023 that R. Brent Jones was appointed Executive Vice President and Chief Financial Officer, effective August 7, 2023. The proxy statement of Avantor, Inc. reports total compensation of $6,538,667 for R. Brent Jones in fiscal 2025, including a base salary of $653,269. Disclosed compensation is on record for 3 fiscal years. R. Brent Jones has spoken on 2 earnings calls across 1 company, most recently for Avantor, Inc. on February 11, 2026. Avantor, Inc. is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Avantor, Inc. includes Michael Stubblefield (CEO), Gregory L. Summe (Chairman), Thomas Szlosek (CFO) and 7 others.
“On March 26, 2026, Mr. R. Brent Jones notified Avantor, Inc. (the "Company") of his decision to resign as the Company's Executive Vice President and Chief Financial Officer ("CFO") to join a company outside the life sciences industry.”
“On July 13, 2023, Avantor, Inc. (the “Company”), announced the appointment of R. Brent Jones as Executive Vice President and Chief Financial Officer, effective as of August 7, 2023.”
“We delivered a Q4 largely in line with expectations with organic revenue growth, adjusted EPS, and free cash flow at or above our guidance. For the quarter, reported revenue was $1.66 billion, which was down 4% year-over-year on an organic basis and squarely in line with our guidance.”
“I'm starting with the numbers on slide five. Fourth quarter reported revenue was $1.69 billion. Taking into account a $40 million impact from the divestiture of our clinical services business, which closed in mid-October, together with the impact of FX, we delivered organic growth of 1%.”
2023-08-07–present
2023-08-07–2026-04-01
AVTR
Medical Instruments & Supplies · Healthcare
CFO
2023-08-07–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Avantor, Inc. (AVTR) | Executive Vice President and Chief Financial Officer | $653,269 | $6,538,667 |
| 2024 | Avantor, Inc. (AVTR) | Executive Vice President and Chief Financial Officer | $611,519 | $3,886,451 |
| 2023 | Avantor, Inc. (AVTR) | Executive Vice President and Chief Financial Officer | $221,154 | $5,840,795 |